FI771772A - - Google Patents

Info

Publication number
FI771772A
FI771772A FI771772A FI771772A FI771772A FI 771772 A FI771772 A FI 771772A FI 771772 A FI771772 A FI 771772A FI 771772 A FI771772 A FI 771772A FI 771772 A FI771772 A FI 771772A
Authority
FI
Finland
Application number
FI771772A
Other languages
Finnish (fi)
Inventor
Gordon Ian Gregory
Peter Clive Cherry
Peter Ward
Christopher Earle Newall
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of FI771772A publication Critical patent/FI771772A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI771772A 1976-06-04 1977-06-03 FI771772A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB23268/76A GB1585124A (en) 1976-06-04 1976-06-04 Clavulanic acid derivatives

Publications (1)

Publication Number Publication Date
FI771772A true FI771772A (ja) 1977-12-05

Family

ID=10192928

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771772A FI771772A (ja) 1976-06-04 1977-06-03

Country Status (15)

Country Link
JP (1) JPS5321193A (ja)
AT (1) AT356814B (ja)
AU (1) AU517897B2 (ja)
BE (1) BE855375A (ja)
CH (1) CH628055A5 (ja)
DE (1) DE2725203A1 (ja)
DK (1) DK247877A (ja)
ES (2) ES459479A1 (ja)
FI (1) FI771772A (ja)
FR (1) FR2353556A1 (ja)
GB (1) GB1585124A (ja)
IL (1) IL52244A0 (ja)
NL (1) NL7706119A (ja)
SE (1) SE7706518L (ja)
ZA (1) ZA773348B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1604822A (en) * 1977-04-22 1981-12-16 Beecham Group Ltd N-monosubstituted-9-amino-9-deoxyclavulanic acid derivative
FR2388814A1 (fr) * 1977-04-27 1978-11-24 Beecham Group Ltd Nouveaux derives de l'acide clavulanique, utilisables comme medicament
EP0003415A3 (en) * 1978-01-20 1979-08-22 Glaxo Group Limited Beta-lactam compounds, processes for their preparation,compositions containing them and intermediates of use in their preparation
DE3066511D1 (en) * 1979-10-26 1984-03-15 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and pharmaceutical compositions containing them
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
EP0068609A1 (en) * 1981-06-11 1983-01-05 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their use
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
IL52244A0 (en) 1977-08-31
BE855375A (fr) 1977-12-05
CH628055A5 (en) 1982-02-15
AU517897B2 (en) 1981-09-03
JPS6135994B2 (ja) 1986-08-15
AT356814B (de) 1980-05-27
ES470333A1 (es) 1979-01-01
ES459479A1 (es) 1978-11-16
DE2725203A1 (de) 1977-12-22
NL7706119A (nl) 1977-12-06
FR2353556B1 (ja) 1980-04-04
AU2580477A (en) 1978-12-07
GB1585124A (en) 1981-02-25
JPS5321193A (en) 1978-02-27
ATA395477A (de) 1979-10-15
DK247877A (da) 1977-12-05
ZA773348B (en) 1978-06-28
FR2353556A1 (fr) 1977-12-30
SE7706518L (sv) 1977-12-04

Similar Documents

Publication Publication Date Title
FR2359686B1 (ja)
JPS52105805U (ja)
JPS52157464U (ja)
CH608969A5 (ja)
DD125869A1 (ja)
CH594961A5 (ja)
CH595902A5 (ja)
CH596538A5 (ja)
CH596798A5 (ja)
CH597742A5 (ja)
CH597906A5 (ja)
CH598547A5 (ja)
CH593206A5 (ja)
CH599484A5 (ja)
BG23465A1 (ja)
CH601079A5 (ja)
CH601889A5 (ja)
CH602243A5 (ja)
CH603191A5 (ja)
CH603277A5 (ja)
CH604498A5 (ja)
CH606714A5 (ja)
CH607273A5 (ja)
CH607440A5 (ja)
CH600491A5 (ja)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: GLAXO LABORATORIES LIMITED